SEC Form 4 · accession 0001209191-17-002818
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred D Kingsley
Officer — See Remarks · Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 6, 2017 · 9:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par valueF1 | Jan 3, 2017 | J | 238,469 | — | D | 1,143,346 | I | By Greenbelt Corp. |
| Common Shares, no par valueF2 | holding | — | — | — | 5,931,555 | D | ||
| Common Shares, no par value | holding | — | — | — | 375,351 | I | By Greenway Partners, LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution to a shareholder in partial redemption of their shares of Greenbelt Corp. None of Mr. Kingsley's shares in Greenbelt Corp. have been redeemed.
- F2Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
Remarks
Mr. Kingsley is Executive Chairman of certain BioTime subsidiaries.